Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End‐Stage Renal Disease
Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia
Tags: analgesic, CYP3A4 N-demethylation, opioid, oxycodone metabolite, µ-opioid receptor (MOR) agonist
BASi Method Number SAP.1358
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
